PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
3.80%
Net income growth under 50% of MRVL's 26.04%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
28.38%
D&A growth well above MRVL's 6.11%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-184.55%
Negative yoy deferred tax while MRVL stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-128.19%
Both reduce yoy usage, with MRVL at -326.47%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
-361.36%
Both reduce yoy inventory, with MRVL at -92.36%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
-80.47%
Both reduce yoy usage, with MRVL at -136.43%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-147.45%
Both negative yoy, with MRVL at -19.55%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-40.03%
Both yoy CFO lines are negative, with MRVL at -6.50%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
23.11%
Some CapEx rise while MRVL is negative at -119.78%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-28.29%
Both yoy lines negative, with MRVL at -4531.20%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
60.29%
Liquidation growth of 60.29% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
16.42%
We have mild expansions while MRVL is negative at -2096.48%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-9.38%
Negative yoy issuance while MRVL is 11.35%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-75.40%
We cut yoy buybacks while MRVL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.